chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Bladder discomfort, Chills, Condition aggravated, Dizziness
Clinical narrative: Injection site discomfort; Dizziness; Burning sensation behind eyes; Ocular migraine; Vision difficulty; Bladder spasms and urgency; Cognitive fog worsened.; Fever; Chills; Arthralgia; Fatigue; Headache; Myalgia; Nausea; This spontaneous case was reported by a nurse and describes the occurrence of INJECTION SITE DISCOMFORT (Injection site discomfort), DIZZINESS (Dizziness), EYE IRRITATION (Burning sensation behind eyes), OPHTHALMIC MIGRAINE (Ocular migraine) and VISUAL IMPAIRMENT (Vision difficulty) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 026L20A) for COVID-19 immunization. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension. Concomitant products included FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Allergy, METOPROLOL SUCCINATE (TOPROL XL) and HYDROCHLOROTHIAZIDE for Hypertension.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INJECTION SITE DISCOMFORT (Injection site discomfort), DIZZINESS (Dizziness), EYE IRRITATION (Burning sensation behind eyes), OPHTHALMIC MIGRAINE (Ocular migraine), VISUAL IMPAIRMENT (Vision difficulty), BLADDER DISCOMFORT (Bladder spasms and urgency), CONDITION AGGRAVATED (Cognitive fog worsened.), PYREXIA (Fever), CHILLS (Chills), ARTHRALGIA (Arthralgia), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Myalgia) and NAUSEA (Nausea). At the time of the report, INJECTION SITE DISCOMFORT (Injection site discomfort), DIZZINESS (Dizziness), EYE IRRITATION (Burning sensation behind eyes), OPHTHALMIC MIGRAINE (Ocular migraine), VISUAL IMPAIRMENT (Vision difficulty), BLADDER DISCOMFORT (Bladder spasms and urgency), CONDITION AGGRAVATED (Cognitive fog worsened.), PYREXIA (Fever), CHILLS (Chills), ARTHRALGIA (Arthralgia), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Myalgia) and NAUSEA (Nausea) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication details were provided.   This case was linked to MOD-2021-011802 (Patient Link).
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Eye irritation, Fatigue, Headache, Injection site discomfort, Myalgia
Clinical narrative: Injection site discomfort; Dizziness; Burning sensation behind eyes; Ocular migraine; Vision difficulty; Bladder spasms and urgency; Cognitive fog worsened.; Fever; Chills; Arthralgia; Fatigue; Headache; Myalgia; Nausea; This spontaneous case was reported by a nurse and describes the occurrence of INJECTION SITE DISCOMFORT (Injection site discomfort), DIZZINESS (Dizziness), EYE IRRITATION (Burning sensation behind eyes), OPHTHALMIC MIGRAINE (Ocular migraine) and VISUAL IMPAIRMENT (Vision difficulty) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 026L20A) for COVID-19 immunization. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension. Concomitant products included FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Allergy, METOPROLOL SUCCINATE (TOPROL XL) and HYDROCHLOROTHIAZIDE for Hypertension.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INJECTION SITE DISCOMFORT (Injection site discomfort), DIZZINESS (Dizziness), EYE IRRITATION (Burning sensation behind eyes), OPHTHALMIC MIGRAINE (Ocular migraine), VISUAL IMPAIRMENT (Vision difficulty), BLADDER DISCOMFORT (Bladder spasms and urgency), CONDITION AGGRAVATED (Cognitive fog worsened.), PYREXIA (Fever), CHILLS (Chills), ARTHRALGIA (Arthralgia), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Myalgia) and NAUSEA (Nausea). At the time of the report, INJECTION SITE DISCOMFORT (Injection site discomfort), DIZZINESS (Dizziness), EYE IRRITATION (Burning sensation behind eyes), OPHTHALMIC MIGRAINE (Ocular migraine), VISUAL IMPAIRMENT (Vision difficulty), BLADDER DISCOMFORT (Bladder spasms and urgency), CONDITION AGGRAVATED (Cognitive fog worsened.), PYREXIA (Fever), CHILLS (Chills), ARTHRALGIA (Arthralgia), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Myalgia) and NAUSEA (Nausea) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication details were provided.   This case was linked to MOD-2021-011802 (Patient Link).
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Ophthalmic migraine, Pyrexia, Visual impairment
Clinical narrative: Injection site discomfort; Dizziness; Burning sensation behind eyes; Ocular migraine; Vision difficulty; Bladder spasms and urgency; Cognitive fog worsened.; Fever; Chills; Arthralgia; Fatigue; Headache; Myalgia; Nausea; This spontaneous case was reported by a nurse and describes the occurrence of INJECTION SITE DISCOMFORT (Injection site discomfort), DIZZINESS (Dizziness), EYE IRRITATION (Burning sensation behind eyes), OPHTHALMIC MIGRAINE (Ocular migraine) and VISUAL IMPAIRMENT (Vision difficulty) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 026L20A) for COVID-19 immunization. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension. Concomitant products included FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Allergy, METOPROLOL SUCCINATE (TOPROL XL) and HYDROCHLOROTHIAZIDE for Hypertension.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INJECTION SITE DISCOMFORT (Injection site discomfort), DIZZINESS (Dizziness), EYE IRRITATION (Burning sensation behind eyes), OPHTHALMIC MIGRAINE (Ocular migraine), VISUAL IMPAIRMENT (Vision difficulty), BLADDER DISCOMFORT (Bladder spasms and urgency), CONDITION AGGRAVATED (Cognitive fog worsened.), PYREXIA (Fever), CHILLS (Chills), ARTHRALGIA (Arthralgia), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Myalgia) and NAUSEA (Nausea). At the time of the report, INJECTION SITE DISCOMFORT (Injection site discomfort), DIZZINESS (Dizziness), EYE IRRITATION (Burning sensation behind eyes), OPHTHALMIC MIGRAINE (Ocular migraine), VISUAL IMPAIRMENT (Vision difficulty), BLADDER DISCOMFORT (Bladder spasms and urgency), CONDITION AGGRAVATED (Cognitive fog worsened.), PYREXIA (Fever), CHILLS (Chills), ARTHRALGIA (Arthralgia), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Myalgia) and NAUSEA (Nausea) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication details were provided.   This case was linked to MOD-2021-011802 (Patient Link).
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Rash
Clinical narrative: Massive rash down arm; tired; slight headache; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Massive rash down arm), FATIGUE (tired) and HEADACHE (slight headache) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027420A and 01M20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (No reported medical history) and Gluten sensitivity.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021 at 4:10 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced RASH (Massive rash down arm), FATIGUE (tired) and HEADACHE (slight headache). On 10-Feb-2021, RASH (Massive rash down arm), FATIGUE (tired) and HEADACHE (slight headache) had resolved.            The patient did not have any acute illness at the time of vaccination and up to 1 month before. The patient had no chronic and long standing health conditions  No concomitant medications reported by investigator o No treatment medications provided by the reporter.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain in extremity, Pyrexia
Clinical narrative: arm pain; body ache; fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm pain), MYALGIA (body ache) and PYREXIA (fever) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm pain), MYALGIA (body ache) and PYREXIA (fever). At the time of the report, PAIN IN EXTREMITY (arm pain), MYALGIA (body ache) and PYREXIA (fever) outcome was unknown.            No concomitant medications were provided by the reporter.  Treatment information was not provided.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Nausea
Clinical narrative: Nausea; Headache; severe fatigue; Severe chills; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea), HEADACHE (Headache), FATIGUE (severe fatigue) and CHILLS (Severe chills) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.    Co-suspect product included non-company product BISOPROLOL for an unknown indication.    The patient's past medical history included No adverse event. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), PANTOPRAZOLE and ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS A & D) for an unknown indication.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started BISOPROLOL (unknown route) at an unspecified dose. On 31-Mar-2021, the patient experienced NAUSEA (Nausea), HEADACHE (Headache), FATIGUE (severe fatigue) and CHILLS (Severe chills). At the time of the report, NAUSEA (Nausea), HEADACHE (Headache), FATIGUE (severe fatigue) and CHILLS (Severe chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue
Clinical narrative: Little tired; chills; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Little tired) and CHILLS (chills) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Hepatic dysfunction NOS and Kidney dysfunction. Concurrent medical conditions included Pulmonary arterial hypertension. Concomitant products included TREPROSTINIL SODIUM (REMODULIN) from 01-Jan-2005 to an unknown date for Pulmonary arterial hypertension.    On 08-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, the patient experienced FATIGUE (Little tired) and CHILLS (chills). At the time of the report, FATIGUE (Little tired) and CHILLS (chills) outcome was unknown.            No concomitant medications provided.   Most recent FOLLOW-UP information incorporated above includes: On 18-Apr-2021: New Event : Chills that night reported.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Hypoaesthesia, Myalgia, Pain in extremity, Pruritus
Clinical narrative: Itchiness; Arm numbness and pain; Arm numbness and pain that raises to the neck; body pain; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchiness), HYPOAESTHESIA (Arm numbness and pain), PAIN IN EXTREMITY (Arm numbness and pain that raises to the neck), MYALGIA (body pain) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced HYPOAESTHESIA (Arm numbness and pain), PAIN IN EXTREMITY (Arm numbness and pain that raises to the neck), MYALGIA (body pain) and CHILLS (Chills). On an unknown date, the patient experienced PRURITUS (Itchiness). At the time of the report, PRURITUS (Itchiness), HYPOAESTHESIA (Arm numbness and pain), PAIN IN EXTREMITY (Arm numbness and pain that raises to the neck), MYALGIA (body pain) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not provided. Patient was scheduled for second dose but cancelled it because of persisting events.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Peripheral swelling
Clinical narrative: Puffed pocket on her arm; Red arm is extemely puffy; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Puffed pocket on her arm) and ERYTHEMA (Red arm is extemely puffy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On an unknown date, the patient experienced PERIPHERAL SWELLING (Puffed pocket on her arm) and ERYTHEMA (Red arm is extemely puffy). At the time of the report, PERIPHERAL SWELLING (Puffed pocket on her arm) and ERYTHEMA (Red arm is extemely puffy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 17 Years and received his vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 Years and received his vaccine) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 Years and received his vaccine). On 06-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 Years and received his vaccine) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Non significant follow up received on 07-MAY-2021, no new information
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Pruritus
Clinical narrative: My inner arms and inner thighs are covered in bruises,; Very itchy all over my body; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Very itchy all over my body) and CONTUSION (My inner arms and inner thighs are covered in bruises,) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, the patient experienced PRURITUS (Very itchy all over my body). On 11-Apr-2021, the patient experienced CONTUSION (My inner arms and inner thighs are covered in bruises,). At the time of the report, PRURITUS (Very itchy all over my body) and CONTUSION (My inner arms and inner thighs are covered in bruises,) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Gastrooesophageal reflux disease, Headache, Illness, Insomnia
Clinical narrative: Was up all night; Could hardly walk; Acid reflux; Felt very sick; Headache; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Was up all night), GAIT DISTURBANCE (Could hardly walk), GASTROOESOPHAGEAL REFLUX DISEASE (Acid reflux), ILLNESS (Felt very sick) and HEADACHE (Headache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 041B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Apr-2021, the patient experienced INSOMNIA (Was up all night), GAIT DISTURBANCE (Could hardly walk), GASTROOESOPHAGEAL REFLUX DISEASE (Acid reflux), ILLNESS (Felt very sick), HEADACHE (Headache) and MYALGIA (Body aches). The patient was treated with ACETAMINOPHEN at an unspecified dose and frequency. At the time of the report, INSOMNIA (Was up all night), GAIT DISTURBANCE (Could hardly walk), GASTROOESOPHAGEAL REFLUX DISEASE (Acid reflux), ILLNESS (Felt very sick), HEADACHE (Headache) and MYALGIA (Body aches) had resolved.            Action taken with mRNA-1273 in response to the events was not applicable.  No concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Follow up received on 16-JUN-2021. Reporter stated that they are fine now and denied for further follow-up.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Was up all night; Could hardly walk; Acid reflux; Felt very sick; Headache; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Was up all night), GAIT DISTURBANCE (Could hardly walk), GASTROOESOPHAGEAL REFLUX DISEASE (Acid reflux), ILLNESS (Felt very sick) and HEADACHE (Headache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 041B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Apr-2021, the patient experienced INSOMNIA (Was up all night), GAIT DISTURBANCE (Could hardly walk), GASTROOESOPHAGEAL REFLUX DISEASE (Acid reflux), ILLNESS (Felt very sick), HEADACHE (Headache) and MYALGIA (Body aches). The patient was treated with ACETAMINOPHEN at an unspecified dose and frequency. At the time of the report, INSOMNIA (Was up all night), GAIT DISTURBANCE (Could hardly walk), GASTROOESOPHAGEAL REFLUX DISEASE (Acid reflux), ILLNESS (Felt very sick), HEADACHE (Headache) and MYALGIA (Body aches) had resolved.            Action taken with mRNA-1273 in response to the events was not applicable.  No concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Follow up received on 16-JUN-2021. Reporter stated that they are fine now and denied for further follow-up.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Swelling
Clinical narrative: Swollen; Pain left shoulder; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Swollen) and ARTHRALGIA (Pain left shoulder) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.). Concomitant products included VITAMINS NOS for an unknown indication.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced ARTHRALGIA (Pain left shoulder). On 13-Apr-2021, the patient experienced SWELLING (Swollen). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of 1 dosage form and DICLOFENAC SODIUM (VOLTAREN [DICLOFENAC SODIUM]) (topical) for Adverse event, at a dose of 1 dosage form. At the time of the report, SWELLING (Swollen) and ARTHRALGIA (Pain left shoulder) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Dizziness, Influenza like illness, Pain in extremity
Clinical narrative: feeling dizzy; mild flu like symptoms; Chills; temperature of 100.6F; little soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (little soreness), DIZZINESS (feeling dizzy), INFLUENZA LIKE ILLNESS (mild flu like symptoms), CHILLS (Chills) and PYREXIA (temperature of 100.6F) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced PAIN IN EXTREMITY (little soreness), INFLUENZA LIKE ILLNESS (mild flu like symptoms), CHILLS (Chills) and PYREXIA (temperature of 100.6F). On 14-Apr-2021, the patient experienced DIZZINESS (feeling dizzy). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (little soreness), DIZZINESS (feeling dizzy), INFLUENZA LIKE ILLNESS (mild flu like symptoms), CHILLS (Chills) and PYREXIA (temperature of 100.6F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Apr-2021, Body temperature: 100.6 (Inconclusive) 100.6 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information included Tylenol.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: feeling dizzy; mild flu like symptoms; Chills; temperature of 100.6F; little soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (little soreness), DIZZINESS (feeling dizzy), INFLUENZA LIKE ILLNESS (mild flu like symptoms), CHILLS (Chills) and PYREXIA (temperature of 100.6F) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced PAIN IN EXTREMITY (little soreness), INFLUENZA LIKE ILLNESS (mild flu like symptoms), CHILLS (Chills) and PYREXIA (temperature of 100.6F). On 14-Apr-2021, the patient experienced DIZZINESS (feeling dizzy). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (little soreness), DIZZINESS (feeling dizzy), INFLUENZA LIKE ILLNESS (mild flu like symptoms), CHILLS (Chills) and PYREXIA (temperature of 100.6F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Apr-2021, Body temperature: 100.6 (Inconclusive) 100.6 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information included Tylenol.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 16y/o (almost 17) daughter/patient received dose 1; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16y/o (almost 17) daughter/patient received dose 1) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16y/o (almost 17) daughter/patient received dose 1). On 31-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16y/o (almost 17) daughter/patient received dose 1) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication use was not reported.   Treatment information was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: Follow-up received on 16-APR-2021 report from pharmacist who administered the vaccine and includes patient and vaccine product information.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: low grade fever of 98.6 degrees; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (low grade fever of 98.6 degrees) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 04B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced PYREXIA (low grade fever of 98.6 degrees). At the time of the report, PYREXIA (low grade fever of 98.6 degrees) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment drugs were reported. Denied consent and refused to give any more information.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: tingling in her face; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling in her face) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Apr-2021 at 6:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced PARAESTHESIA (tingling in her face). At the time of the report, PARAESTHESIA (tingling in her face) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reported no concomitant medications.   Treatment information was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Underdose, Vaccination site discharge
Clinical narrative: during course of administration some of the vaccine leaked out of her arm; during course of administration some of the vaccine leaked out of her arm; This spontaneous case was reported by a consumer and describes the occurrence of UNDERDOSE (during course of administration some of the vaccine leaked out of her arm) and VACCINATION SITE DISCHARGE (during course of administration some of the vaccine leaked out of her arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced UNDERDOSE (during course of administration some of the vaccine leaked out of her arm) and VACCINATION SITE DISCHARGE (during course of administration some of the vaccine leaked out of her arm). At the time of the report, UNDERDOSE (during course of administration some of the vaccine leaked out of her arm) and VACCINATION SITE DISCHARGE (during course of administration some of the vaccine leaked out of her arm) outcome was unknown.            No concomitant medications were reported.  No treatment information was reported.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 016B21A) for COVID-19 vaccination.     Concurrent medical conditions included Anxiety. Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT) for Anxiety.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm pain). At the time of the report, PAIN IN EXTREMITY (Arm pain) outcome was unknown.            Concomitant product use was not provided by the reporter. Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Exposure via breast milk
Clinical narrative: she is breastfeeding; This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE VIA BREAST MILK (she is breastfeeding) in a  patient of an unknown age and gender exposed to mRNA-1273 (Moderna COVID-19 Vaccine) , while the mother received the product for COVID-19 vaccination.    MEDICAL HISTORY (Parent): Concurrent medical conditions included Maternal exposure during breast feeding.    No Medical History information was reported.    On 05-Apr-2021, the mother received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 05-Apr-2021, the patient was diagnosed with EXPOSURE VIA BREAST MILK (she is breastfeeding). On 05-Apr-2021, EXPOSURE VIA BREAST MILK (she is breastfeeding) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Information about concomitant medications and treatments were not provided by the reporter.   This case was linked to MOD-2021-075635 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: tested positive for Covid after second dose; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for Covid after second dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, the patient experienced COVID-19 (tested positive for Covid after second dose). At the time of the report, COVID-19 (tested positive for Covid after second dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Apr-2021, SARS-CoV-2 test: positive (Positive) Positive.         Concomitant medication use was not reported.   It was noted per source that the patient thought he had COVID before getting tested but he did not have any symptoms.   Treatment in formation was not reported.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Ear discomfort, Headache, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: discomfort in inner right ear; redness and itching in injection site; headache; redness and itching in injection site; This spontaneous case was reported by a consumer and describes the occurrence of EAR DISCOMFORT (discomfort in inner right ear), VACCINATION SITE PRURITUS (redness and itching in injection site), HEADACHE (headache) and VACCINATION SITE ERYTHEMA (redness and itching in injection site) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008B21A and 027A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced EAR DISCOMFORT (discomfort in inner right ear), VACCINATION SITE PRURITUS (redness and itching in injection site), HEADACHE (headache) and VACCINATION SITE ERYTHEMA (redness and itching in injection site). At the time of the report, EAR DISCOMFORT (discomfort in inner right ear), VACCINATION SITE PRURITUS (redness and itching in injection site), HEADACHE (headache) and VACCINATION SITE ERYTHEMA (redness and itching in injection site) outcome was unknown.            No concomitant medications were reported. No treatment information was reported. Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: Follow up received on 06-MAY-2021 Contains Reporter/patient contact information updated upon returning call from safety. On 07-May-2021: Follow up received on 07-MAY-2021 Contains Reporter/patient contact information updated upon returning call from safety, no new information provided.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Inappropriate schedule of product administration, Pyrexia
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of pyrexia (temperature of about 101ºF) and inappropriate schedule of product administration (2nd dose sooner than 26 days) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 045A2A and 038B21A) for COVID-19 immunization. No medical history reported. On Mar 19, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient had pyrexia (temperature of about 101ºF) and inappropriate schedule of product administration (2nd dose sooner than 26 days). At the time of the report, pyrexia (temperature of about 101ºF) and inappropriate schedule of product administration (2nd dose sooner than 26 days) outcome: unknown/not provided. Diagnostic results: On an unknown date, high body temperature: of about 101ºF after the 2nd dose. Action taken with mRNA-1273 in response to the events: not applicable. Concomitant product use and treatment information not provided.
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: swollen lymph node in left collar bone region; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of LYMPHADENOPATHY (swollen lymph node in left collar bone region) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, the patient experienced LYMPHADENOPATHY (swollen lymph node in left collar bone region). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, LYMPHADENOPATHY (swollen lymph node in left collar bone region) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Pruritus, Skin mass, Swelling
Clinical narrative: knots on the injection side that wen from below her ear to her elbow and down the side of her leg; itchy; allergic reaction to the vaccine; she had lumps down arm and around ear; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SKIN MASS (knots on the injection side that wen from below her ear to her elbow and down the side of her leg), PRURITUS (itchy), HYPERSENSITIVITY (allergic reaction to the vaccine) and SWELLING (she had lumps down arm and around ear) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SKIN MASS (knots on the injection side that wen from below her ear to her elbow and down the side of her leg), PRURITUS (itchy), HYPERSENSITIVITY (allergic reaction to the vaccine) and SWELLING (she had lumps down arm and around ear). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, SKIN MASS (knots on the injection side that wen from below her ear to her elbow and down the side of her leg), PRURITUS (itchy), HYPERSENSITIVITY (allergic reaction to the vaccine) and SWELLING (she had lumps down arm and around ear) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication include lotion.  No concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: significant follow up appended on 16  April 2021. Added information about concomitant medication and an event (swelling)
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Petechiae, Pyrexia
Clinical narrative: Petechiae on face; Low grade fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PETECHIAE (Petechiae on face), PYREXIA (Low grade fever) and HEADACHE (Headache) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ASCORBIC ACID, ERGOCALCIFEROL, NICOTINAMIDE, RETINOL, RIBOFLAVIN, THIAMINE HYDROCHLORIDE (VITAMINS [ASCORBIC ACID;ERGOCALCIFEROL;NICOTINAMIDE;RETINOL;RIBOFLAVIN;THIAMINE HYDROCHLORIDE]) and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced PYREXIA (Low grade fever) and HEADACHE (Headache). On 05-Apr-2021, the patient experienced PETECHIAE (Petechiae on face). At the time of the report, PETECHIAE (Petechiae on face), PYREXIA (Low grade fever) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information in response to events was not provided.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Confusional state, Disturbance in attention, Eye pain, Fatigue, Feeling abnormal
Clinical narrative: foggy brain and can't remember who he is; "feeling like an idiot."; has difficulty to remember where he can't speak or remember anything; eyes feel pain and are uncomfortable; sick; "brain is so bland and empty."; cannot focus or concentrate; had so many side effects; had some headaches and some brain pain that affected his two eyes; on the right side of brain, it is painful on the backside; fatigue; arm pain; felt numb in his two hands, two feet; sweaty; cannot sleep all night; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (arm pain), HYPOAESTHESIA (felt numb in his two hands, two feet), HYPERHIDROSIS (sweaty), INSOMNIA (cannot sleep all night) and FEELING ABNORMAL (foggy brain and can't remember who he is; "feeling like an idiot.") in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced INSOMNIA (cannot sleep all night). On an unknown date, the patient experienced PAIN IN EXTREMITY (arm pain), HYPOAESTHESIA (felt numb in his two hands, two feet), HYPERHIDROSIS (sweaty), FEELING ABNORMAL (foggy brain and can't remember who he is; "feeling like an idiot."), MEMORY IMPAIRMENT (has difficulty to remember where he can't speak or remember anything), EYE PAIN (eyes feel pain and are uncomfortable), ILLNESS (sick), CONFUSIONAL STATE ("brain is so bland and empty."), DISTURBANCE IN ATTENTION (cannot focus or concentrate), VACCINATION COMPLICATION (had so many side effects), HEADACHE (had some headaches and some brain pain that affected his two eyes; on the right side of brain, it is painful on the backside) and FATIGUE (fatigue). At the time of the report, PAIN IN EXTREMITY (arm pain), HYPOAESTHESIA (felt numb in his two hands, two feet), HYPERHIDROSIS (sweaty), INSOMNIA (cannot sleep all night), FEELING ABNORMAL (foggy brain and can't remember who he is; "feeling like an idiot."), MEMORY IMPAIRMENT (has difficulty to remember where he can't speak or remember anything), EYE PAIN (eyes feel pain and are uncomfortable), ILLNESS (sick), CONFUSIONAL STATE ("brain is so bland and empty."), DISTURBANCE IN ATTENTION (cannot focus or concentrate), VACCINATION COMPLICATION (had so many side effects), HEADACHE (had some headaches and some brain pain that affected his two eyes; on the right side of brain, it is painful on the backside) and FATIGUE (fatigue) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided by the reporter.  The patient went to the emergency room on 12APR2021, but "they did not detect anything."  Treatment information was not provided.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Hyperhidrosis, Hypoaesthesia, Illness, Insomnia
Clinical narrative: foggy brain and can't remember who he is; "feeling like an idiot."; has difficulty to remember where he can't speak or remember anything; eyes feel pain and are uncomfortable; sick; "brain is so bland and empty."; cannot focus or concentrate; had so many side effects; had some headaches and some brain pain that affected his two eyes; on the right side of brain, it is painful on the backside; fatigue; arm pain; felt numb in his two hands, two feet; sweaty; cannot sleep all night; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (arm pain), HYPOAESTHESIA (felt numb in his two hands, two feet), HYPERHIDROSIS (sweaty), INSOMNIA (cannot sleep all night) and FEELING ABNORMAL (foggy brain and can't remember who he is; "feeling like an idiot.") in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced INSOMNIA (cannot sleep all night). On an unknown date, the patient experienced PAIN IN EXTREMITY (arm pain), HYPOAESTHESIA (felt numb in his two hands, two feet), HYPERHIDROSIS (sweaty), FEELING ABNORMAL (foggy brain and can't remember who he is; "feeling like an idiot."), MEMORY IMPAIRMENT (has difficulty to remember where he can't speak or remember anything), EYE PAIN (eyes feel pain and are uncomfortable), ILLNESS (sick), CONFUSIONAL STATE ("brain is so bland and empty."), DISTURBANCE IN ATTENTION (cannot focus or concentrate), VACCINATION COMPLICATION (had so many side effects), HEADACHE (had some headaches and some brain pain that affected his two eyes; on the right side of brain, it is painful on the backside) and FATIGUE (fatigue). At the time of the report, PAIN IN EXTREMITY (arm pain), HYPOAESTHESIA (felt numb in his two hands, two feet), HYPERHIDROSIS (sweaty), INSOMNIA (cannot sleep all night), FEELING ABNORMAL (foggy brain and can't remember who he is; "feeling like an idiot."), MEMORY IMPAIRMENT (has difficulty to remember where he can't speak or remember anything), EYE PAIN (eyes feel pain and are uncomfortable), ILLNESS (sick), CONFUSIONAL STATE ("brain is so bland and empty."), DISTURBANCE IN ATTENTION (cannot focus or concentrate), VACCINATION COMPLICATION (had so many side effects), HEADACHE (had some headaches and some brain pain that affected his two eyes; on the right side of brain, it is painful on the backside) and FATIGUE (fatigue) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided by the reporter.  The patient went to the emergency room on 12APR2021, but "they did not detect anything."  Treatment information was not provided.